These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19018783)

  • 1. Low-dose pioglitazone and low-dose flutamide added to metformin and oestro-progestagens for hyperinsulinaemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months.
    Ibáñez L; López-Bermejo A; Díaz M; Enríquez G; del Río L; de Zegher F
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):351-7. PubMed ID: 19018783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioglitazone (7.5 mg/day) added to flutamide-metformin in women with androgen excess: additional increments of visfatin and high molecular weight adiponectin.
    Ibáñez L; López-Bermejo A; Díaz M; Enríquez G; Valls C; de Zegher F
    Clin Endocrinol (Oxf); 2008 Feb; 68(2):317-20. PubMed ID: 18031315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess.
    Ibáñez L; López-Bermejo A; del Rio L; Enríquez G; Valls C; de Zegher F
    J Clin Endocrinol Metab; 2007 May; 92(5):1710-4. PubMed ID: 17299064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism.
    Ibáñez L; Ong K; Ferrer A; Amin R; Dunger D; de Zegher F
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2600-6. PubMed ID: 12788862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethinyl estradiol-cyproterone acetate versus low-dose pioglitazone-flutamide-metformin for adolescent girls with androgen excess: divergent effects on CD163, TWEAK receptor, ANGPTL4, and LEPTIN expression in subcutaneous adipose tissue.
    Díaz M; Chacón MR; López-Bermejo A; Maymó-Masip E; Salvador C; Vendrell J; de Zegher F; Ibáñez L
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3630-8. PubMed ID: 22791755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception.
    Ibáñez L; De Zegher F
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4720-4. PubMed ID: 14557446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of androgen excess in adolescent girls: ethinylestradiol-cyproteroneacetate versus low-dose pioglitazone-flutamide-metformin.
    Ibáñez L; Diaz M; Sebastiani G; Sánchez-Infantes D; Salvador C; Lopez-Bermejo A; de Zegher F
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3361-6. PubMed ID: 21865363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
    Ibáñez L; de Zegher F
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1592-7. PubMed ID: 15070917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose pioglitazone, flutamide, metformin plus an estro-progestagen for non-obese young women with polycystic ovary syndrome: increasing efficacy and persistent safety over 30 months.
    Ibáñez L; López-Bermejo A; Díaz M; Enríquez G; Del Río L; De Zegher F
    Gynecol Endocrinol; 2010 Dec; 26(12):869-73. PubMed ID: 20500100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flutamide-metformin plus an oral contraceptive (OC) for young women with polycystic ovary syndrome: switch from third- to fourth-generation OC reduces body adiposity.
    Ibáñez L; De Zegher F
    Hum Reprod; 2004 Aug; 19(8):1725-7. PubMed ID: 15229206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception.
    Ibáñez L; Jaramillo AM; Ferrer A; de Zegher F
    Hum Reprod; 2005 Sep; 20(9):2457-62. PubMed ID: 15905296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discontinuous low-dose flutamide-metformin plus an oral or a transdermal contraceptive in patients with hyperinsulinaemic hyperandrogenism: normalizing effects on CRP, TNF-alpha and the neutrophil/lymphocyte ratio.
    Ibáñez L; Valls C; de Zegher F
    Hum Reprod; 2006 Feb; 21(2):451-6. PubMed ID: 16239318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraception vs insulin sensitization for 18 months in nonobese adolescents with androgen excess: posttreatment differences in C-reactive protein, intima-media thickness, visceral adiposity, insulin sensitivity, and menstrual regularity.
    Ibáñez L; Díaz M; Sebastiani G; Marcos MV; López-Bermejo A; de Zegher F
    J Clin Endocrinol Metab; 2013 May; 98(5):E902-7. PubMed ID: 23547047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women.
    Ibáñez L; de Zegher F
    Hum Reprod Update; 2006; 12(3):243-52. PubMed ID: 16407452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Divergent effects of ethinylestradiol-drospirenone and flutamide-metformin on follistatin in adolescents and women with hyperinsulinemic androgen excess.
    Ibáñez L; Díaz M; López-Bermejo A; de Zegher F
    Gynecol Endocrinol; 2011 Mar; 27(3):197-8. PubMed ID: 20528210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study.
    Gambineri A; Patton L; Vaccina A; Cacciari M; Morselli-Labate AM; Cavazza C; Pagotto U; Pasquali R
    J Clin Endocrinol Metab; 2006 Oct; 91(10):3970-80. PubMed ID: 16868063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in nonobese adolescents and women.
    Ibáñez L; de Zegher F
    Fertil Steril; 2006 Jul; 86 Suppl 1():S24-5. PubMed ID: 16798281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy.
    Ibáñez L; de Zegher F
    J Clin Endocrinol Metab; 2005 Jan; 90(1):39-43. PubMed ID: 15483105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome.
    Gambineri A; Pelusi C; Genghini S; Morselli-Labate AM; Cacciari M; Pagotto U; Pasquali R
    Clin Endocrinol (Oxf); 2004 Feb; 60(2):241-9. PubMed ID: 14725687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naïve patients with type 2 diabetes.
    Pérez-Monteverde A; Seck T; Xu L; Lee MA; Sisk CM; Williams-Herman DE; Engel SS; Kaufman KD; Goldstein BJ
    Int J Clin Pract; 2011 Sep; 65(9):930-8. PubMed ID: 21849007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.